Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Cylene Pharmaceuticals and TetraGene Enter Agreement for Quarfloxin and Anticancer Quadruplex Technologies Agreement Includes Phase II Compound
Cylene Pharmaceuticals and TetraGene Enter Agreement for Quarfloxin and Anticancer Quadruplex Technologies Agreement Includes Phase II Compound
Cylene Pharmaceuticals and TetraGene Enter Agreement for Quarfloxin and Anticancer Quadruplex Technologies Agreement Includes Phase II Compound
Submitted by
admin
on March 6, 2013 - 11:08am
Source:
Sacramento Bee, CA
News Tags:
Cylene Pharmaceuticals
TetraGene
Quarfloxin
cancer
Headline:
Cylene Pharmaceuticals and TetraGene Enter Agreement for Quarfloxin and Anticancer Quadruplex Technologies Agreement Includes Phase II Compound
Do Not Allow Advertisers to Use My Personal information
